189 related articles for article (PubMed ID: 28431200)
41. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
[TBL] [Abstract][Full Text] [Related]
42. Cytoplasmic Expression of CD3ε Heterodimers by Flow Cytometry Rapidly Distinguishes Between Mature T-Cell and Natural Killer-Cell Neoplasms.
Shi M; Nguyen P; Timm MM; Otteson GE; Horna P; Olteanu H; Jevremovic D
Am J Clin Pathol; 2020 Oct; 154(5):683-691. PubMed ID: 32589191
[TBL] [Abstract][Full Text] [Related]
43. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
44. Increased oxidative stress contributes to impaired peripheral CD56
Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
[TBL] [Abstract][Full Text] [Related]
46. Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.
Gerstner S; Köhler W; Heidkamp G; Purbojo A; Uchida S; Ekici AB; Heger L; Luetke-Eversloh M; Schubert R; Bader P; Klingebiel T; Koehl U; Mackensen A; Romagnani C; Cesnjevar R; Dudziak D; Ullrich E
J Leukoc Biol; 2016 Dec; 100(6):1297-1310. PubMed ID: 27354408
[TBL] [Abstract][Full Text] [Related]
47. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
[TBL] [Abstract][Full Text] [Related]
48. Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients.
Katchar K; Söderström K; Wahlstrom J; Eklund A; Grunewald J
Eur Respir J; 2005 Jul; 26(1):77-85. PubMed ID: 15994392
[TBL] [Abstract][Full Text] [Related]
49. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
[TBL] [Abstract][Full Text] [Related]
50. Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets.
Eidukaite A; Siaurys A; Tamosiunas V
Fertil Steril; 2004 Mar; 81 Suppl 1():863-8. PubMed ID: 15019821
[TBL] [Abstract][Full Text] [Related]
51. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
52. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.
Nguyen T; Johnston S; Clarke L; Smith P; Staines D; Marshall-Gradisnik S
Clin Exp Immunol; 2017 Feb; 187(2):284-293. PubMed ID: 27727448
[TBL] [Abstract][Full Text] [Related]
53. Aggressive natural killer cell leukemia/lymphoma with N901-positive surface phenotype: evidence for the existence of a third lineage in lymphoid cells.
Imamura N; Kusunoki Y; Kajihara H; Okada K; Kuramoto A
Acta Haematol; 1988; 80(3):121-8. PubMed ID: 2461636
[TBL] [Abstract][Full Text] [Related]
54. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
[TBL] [Abstract][Full Text] [Related]
55. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens.
Bradstock KF; Luxford C; Grimsley PG
Immunol Cell Biol; 1993 Dec; 71 ( Pt 6)():535-42. PubMed ID: 7508887
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study.
Basak PY; Adiloglu AK; Koc IG; Tas T; Akkaya VB
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):970-6. PubMed ID: 18482314
[TBL] [Abstract][Full Text] [Related]
57. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
[TBL] [Abstract][Full Text] [Related]
58. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S
Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393
[TBL] [Abstract][Full Text] [Related]
59. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
Chang YJ; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
[TBL] [Abstract][Full Text] [Related]
60. Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells.
Merkt W; Claus M; Blank N; Hundemer M; Cerwenka A; Lorenz HM; Watzl C
Arthritis Res Ther; 2016 Sep; 18(1):204. PubMed ID: 27624647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]